BWX Technologies (BWXT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 2, 2025, via virtual webcast; record date is March 6, 2025.
Key proposals: election of nine directors, advisory vote on executive compensation, amendment to limit officer liability, and auditor ratification.
2024 performance: $2.7B revenue (8% increase), $282.3M net income, $498.7M adjusted EBITDA, $3.07 GAAP EPS, $3.33 non-GAAP EPS, $108.3M returned to shareholders.
As of year-end 2024, backlog was $4.8B; total stockholder return tracked against S&P 500 and industry peers.
Voting matters and shareholder proposals
Proposals: elect nine directors, advisory say-on-pay, amend certificate to limit officer liability, ratify Deloitte as auditor.
Board recommends voting FOR all proposals.
Shareholders can vote online, by phone, mail, or during the virtual meeting.
Shareholder proposals for 2026 must be submitted by November 19, 2025.
Board of directors and corporate governance
Board is 90% independent, 40% gender/racial diversity, average tenure 6.9 years, average age 66.3.
12-year director tenure limit and annual election of directors.
Independent Board Chair; all committees are fully independent.
Board committees: Audit and Finance, Compensation, Governance; each has defined charters and responsibilities.
Regular board and committee self-evaluations, robust stock ownership guidelines, and no dual-class stock.
Latest events from BWX Technologies
- 2026 outlook projects high-teens revenue growth and double-digit free cash flow, fueled by nuclear demand.BWXT
Investor presentation18 Mar 2026 - Virtual annual meeting to elect directors, approve pay, and ratify auditor on April 30, 2026.BWXT
Proxy Filing18 Mar 2026 - Record 2025 growth and strong 2026 outlook driven by nuclear demand and major contract wins.BWXT
Q4 202523 Feb 2026 - Q2 2024 delivered double-digit growth and a higher EPS outlook amid strong industry demand.BWXT
Q2 20242 Feb 2026 - Q3 2024 delivered 14% revenue growth, higher EPS, and a major special materials acquisition.BWXT
Q3 202417 Jan 2026 - $525M acquisition expands nuclear and isotope services, boosting global reach and workforce.BWXT
M&A Announcement10 Jan 2026 - Record revenue, backlog, and free cash flow drive strong 2025 growth outlook.BWXT
Q4 20247 Jan 2026 - Q1 2025 revenue up 13%, net income $75.5M, backlog $4.88B, 2025 outlook reaffirmed.BWXT
Q1 202525 Dec 2025 - Board recommends all proposals, highlights strong governance, pay-for-performance, and ESG focus.BWXT
Proxy Filing1 Dec 2025